Study to Evaluate a Single Dose of LTX-109 in Subjects With COVID-19 (Coronavirus Disease 2019) Infection.
Clinical trial NCT04854928 · UNKNOWN
Trial details
- NCT number
- NCT04854928
- Sponsor
- Pharma Holdings AS
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-03
- Primary completion
- 2022-02-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.